The Prostate project consists in the development of an assisted diagnosis system, based on Artificial Intelligence technology capable of identifying and classifying the presence of prostate neoplasms. In addition, Health Triage technology aims to make the examination much less invasive than the current diagnostic process, replacing, where possible, the random biopsy. As a matter of fact, this patented technology automatically integrates the anatomical and functional images of the magnetic resonance to produce a single synthetic map of the tumor area, providing information on the position, volume and aggressiveness of the tumor, elements that could avoid biopsy in cases of low aggressiveness.
The less invasive characteristics of this innovative technique could open new fields of application such as Active Surveillance in patients who are positive but who need periodic checks and new prevention programs on asymptomatic patients.
Prostate cancer (PCa) is one of the most common cancers in the male population and accounts for approximately 20 percent of all cancers diagnosed in humans. It is the second leading cause of cancer death in industrialized countries, preceded only by lung cancer. The increase in the population and its simultaneous aging are expected to result in a significant increase in the number of PCa cases in the coming years. It is necessary to say that the data related to the survival of people who have been diagnosed with prostate cancer (about 90 percent after five years of diagnosis) are very encouraging, especially if we intervene in time.